Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Bethesda, Maryland 20892


Purpose:

RATIONALE: Animal-assisted therapy and recreation therapy may help relieve mental and physical distress in cancer patients being treated for pain and help them live more comfortably. PURPOSE: This randomized clinical trial is studying how well animal-assisted therapy and recreation therapy works in relieving distress in cancer patients undergoing treatment for pain.


Study summary:

OBJECTIVES: Primary - Determine the effect of animal-assisted therapy and recreational therapy on psychological and physiological distress in oncology patients being treated for pain. Secondary - Determine the effect of these therapies on the level of pain unpleasantness and the use of PRN pain medications in these patients. - Determine the effect of these therapies on the level of pain intensity in these patients. - Determine the effect of these therapies on patient attitudes towards pets. OUTLINE: This is a randomized, cross-over study. Patients are randomized to 1 of 2 arms. - Arm I: Patients undergo a 20-minute animal-assisted therapy (AAT) session with an AAT dog and dog owner on day 1 followed by a 20-minute session with a recreational therapist on day 2. - Arm II: Patients undergo a 20-minute session with a recreational therapist on day 1 followed by a 20-minute AAT session with a dog and dog owner on day 2. Patients in both arms complete two questionnaires before and after each therapy session to measure physiological and psychological distress related to pain. Patients also undergo measurement of pain-related physiological distress by assessment of salivary cortisol. For patients with indwelling catheters, serum beta-endorphin levels are measured as markers of distress. Medication use data are collected every 24 hours during study. PROJECTED ACCRUAL: A total of 150 patients will be accrued for this study.


Criteria:

DISEASE CHARACTERISTICS: - Diagnosis of cancer - Currently enrolled in a primary research protocol and referred for consult to the National Institute of Health's pain and palliative care team and/or recreation therapy - Participation in this study is contingent upon approval of principal investigator of primary protocol - Participation in this study may not interrupt or alter primary cancer therapy - Rating of ≥ 4 on the distress scale and/or 6 yes boxes checked PATIENT CHARACTERISTICS: - Able to speak English and read at a 5th-grade level - No allergies to or fear of dogs - No strict contact or respiratory isolation restrictions - No neutropenia PRIOR CONCURRENT THERAPY: - See Disease Characteristics


NCT ID:

NCT00103688


Primary Contact:

Principal Investigator
Ann Berger, MD, MSN
NIH - Warren Grant Magnuson Clinical Center


Backup Contact:

N/A


Location Contact:

Bethesda, Maryland 20892
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.